Baird Financial Group’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-135,154	Closed	-$5.85M	–	1853
2021 Q2	$5.85M	Buy	135,154 +380	+0.3%	+$16.2K	0.02%	549
2021 Q1	$5.5M	Sell	134,774 -1,526	-1%	-$57.9K	0.02%	549
2020 Q4	$6.17M	Sell	136,300 -103,067	-43%	-$3.91M	0.02%	489
2020 Q3	$8.47M	Buy	239,367 +4,917	+2%	+$178K	0.03%	392
2020 Q2	$8.85M	Buy	234,450 +113,328	+94%	+$3.73M	0.03%	370
2020 Q1	$3.5M	Sell	121,122 -55,253	-31%	-$2.23M	0.02%	523
2019 Q4	$9.14M	Sell	176,375 -2,038	-1%	-$118K	0.03%	392
2019 Q3	$9.79M	Sell	178,413 -868	-0.5%	-$44.6K	0.04%	356
2019 Q2	$7.28M	Buy	179,281 +10,323	+6%	+$376K	0.03%	422
2019 Q1	$5.11M	Buy	168,958 +158,906	+1,581%	+$5.44M	0.03%	440
2018 Q4	$338K	Sell	10,052 -89,412	-90%	-$3.23M	﹤0.01%	1076
2018 Q3	$4.16M	Buy	99,464 +8,949	+10%	+$354K	0.03%	484
2018 Q2	$2.9M	Buy	90,515 +9,318	+11%	+$384K	0.02%	561
2018 Q1	$4.04M	Buy	81,197 +32,777	+68%	+$1.85M	0.03%	464
2017 Q4	$2.61M	Buy	48,420 +839	+2%	+$46.4K	0.02%	550
2017 Q3	$2.76M	Sell	47,581 -416	-0.9%	-$21.7K	0.02%	541
2017 Q2	$2.37M	Buy	+47,997	New	+$2.21M	0.02%	563